Unlocking the Potential of a New Method to Combat RNA Viruses Like SARS-CoV-2
Researchers at the University of Toronto have developed a new method for treating RNA viruses, such as SARS-CoV-2. This innovative approach uses a modified form of an enzyme known as an RNA helicase, which is capable of recognizing and binding to a specific type of RNA sequence, allowing it to target RNA viruses. This method could be used to treat a variety of illnesses, including COVID-19.
The study, published in Nature Communications, explains how this method works and how it could be used to prevent and treat RNA viruses. The researchers used a modified form of an enzyme known as an RNA helicase, which recognizes and binds to a specific type of RNA sequence. This allowed the enzyme to target RNA viruses and stop them from replicating. The team also developed a method of delivering the enzyme directly to cells infected with the virus, allowing them to be treated more quickly and efficiently.
This new method could have a major impact on treating RNA viruses like SARS-CoV-2. By targeting the virus directly, it could potentially help to reduce the severity of symptoms and prevent the virus from spreading further.
source: Phys.org